oxybutynin has been researched along with Bradykinesia in 1 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Excerpt | Relevance | Reference |
---|---|---|
"Nocturnal hypokinesia is a common symptom in Parkinson's disease (PD), negatively affecting quality of life of both patients and caregivers." | 2.84 | Rotigotine for nocturnal hypokinesia in Parkinson's disease: Quantitative analysis of efficacy from a randomized, placebo-controlled trial using an axial inertial sensor. ( Anan, C; Bhidayasiri, R; Boonpang, K; Chaiwong, S; Jagota, P; Leaknok, A; Penkeaw, N; Rattanachaisit, W; Saksornchai, K; Sringean, J; Thanawattano, C, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhidayasiri, R | 1 |
Sringean, J | 1 |
Chaiwong, S | 1 |
Anan, C | 1 |
Penkeaw, N | 1 |
Leaknok, A | 1 |
Boonpang, K | 1 |
Saksornchai, K | 1 |
Rattanachaisit, W | 1 |
Thanawattano, C | 1 |
Jagota, P | 1 |
1 trial available for oxybutynin and Bradykinesia
Article | Year |
---|---|
Rotigotine for nocturnal hypokinesia in Parkinson's disease: Quantitative analysis of efficacy from a randomized, placebo-controlled trial using an axial inertial sensor.
Topics: Accelerometry; Aged; Dopamine Agonists; Female; Humans; Hypokinesia; Male; Middle Aged; Parkinson Di | 2017 |